Know Cancer

or
forgot password

PATIENT-REPORTED OUTCOMES FOR GAY MEN WITH LOCALIZED PROSTATE CANCER


N/A
18 Years
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

PATIENT-REPORTED OUTCOMES FOR GAY MEN WITH LOCALIZED PROSTATE CANCER


OBJECTIVES:

- To enroll 200 gay men with localized prostate cancer in a cross-sectional study of
prostate cancer outcomes.

- To complete an R01 application using pilot data collected from these patients.

- To complete manuscripts describing the factors that influence quality of life and
treatment satisfaction in these patients.

OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA
at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of
healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress,
and psychosocial factors (ethnicity, health literacy, level of social support, communication
with provider, relationship status, and communication with partner) that affect their
health-related quality of life. The data will be used to provide the information necessary
to tailor an existing prostate cancer survivorship intervention to address the specific
needs of gay men with prostate cancer.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of localized prostate cancer

- No advanced disease

- Self-identified as gay

PATIENT CHARACTERISTICS:

- Able to complete an online questionnaire

- Able to speak and understand English

PRIOR CONCURRENT THERAPY:

- Not specified

Type of Study:

Observational

Study Design:

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Outcome Measure:

Effect of disease factors and treatment factors on subjective well-being

Outcome Time Frame:

Cross-sectional retrospective study, one timepoint

Safety Issue:

No

Principal Investigator

David M. Latini, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baylor College of Medicine

Authority:

United States: Institutional Review Board

Study ID:

CDR0000600597

NCT ID:

NCT00828633

Start Date:

August 2008

Completion Date:

December 2012

Related Keywords:

  • Prostate Cancer
  • stage I prostate cancer
  • stage II prostate cancer
  • Prostatic Neoplasms

Name

Location

Veterans Affairs Medical Center - HoustonHouston, Texas  77030
Dan L. Duncan Cancer Center at Baylor College of MedicineHouston, Texas  77030
Arizona State University - West CampusPhoenix, Arizona  85069